Targeted Treatment for vaginitis
Mucosamin® Vaginal Cream
Mucosamin® vaginal cream
helps heal vulvovaginitis induced
by cancer treatment.
Vaginitis is inflammation of the vagina that can cause itching, discomfort and discharge.1
Mucosamin® vaginal cream is a medical device, which helps with the healing process of the vaginal mucosa and aids in the treatment of painful symptoms of actinic vulvovaginitis caused by radiation treatment of the pelvic region and vulvovaginitis caused during chemotherapy or a combination of both treatments (chemotherapy and radiotherapy).2
How does Mucosamin® Vaginal cream work?
Mucosamin® contains hyaluronic acid (sodium hyaluronate), which is the main component of connective tissue and amino acid precursors of structural proteins of the extracellular matrix.2,3
Mucosamin® is an approved Class IIb medical device and consists of a natural polysaccharide that forms a mucoadhesive layer on the surface epithelial cells.2
Mucosamin® Vaginal Cream reduces painful symptoms by creating a protective layer over erythematous or ulcerated mucosa.2
Mucosamin® Vaginal Cream contains hyaluronic acid and amino acids to promote repair and growth of epithelial and collagen tissue, healing the mucosa.2
1. NHS Vaginitis https://www.nhs.uk/conditions/vaginitis/ (accessed January 2019)
2. Mucosamin® Vaginal Cream Instructions for Use. 2016
3. Colella, G. et al. Efficacy of a spray compound containing a pool of collagen precursor synthetic amino acids (L-Proline, L-Leucine, L-Lysine and Glycine) combined with sodium hyaluronate to manage chemo/radiotherapy-induced oral mucositis. Int J Immunopathol Pharmacol. 2010: 23(1): 143-151
DEPENDABLE SUPPLY CHAIN.
For further information please call: 01730 231148,
email: firstname.lastname@example.org or visit www.aspirepharma.co.uk
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
Reporting of Side Effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the product’s package leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard. By reporting side effects you can help provide more information on the safety of this medicine.
For more information about Mucosamin, please see the abbreviated prescribing information.